BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival

Abstract

The BAD apoptosis pathway influences OVCA chemosensitivity and overall survival, likely via modulation of BAD phosphorylation. The pathway has clinical relevance as a biomarker of therapeutic response, patient survival, and as a promising therapeutic target.